Avalo Therapeutics Cash from Investing (TTM) Analysis

Avalo Therapeutics Inc (AVTX)

15.37 +0.39 (+2.60%) USD | NASDAQ | Apr 26, 16:00

15.52 +0.15 (+0.98%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	-0.133M
September 30, 2023	-0.133M
June 30, 2023	-0.172M
March 31, 2023	-0.228M
December 31, 2022	-0.095M
September 30, 2022	-0.106M
June 30, 2022	-0.148M
March 31, 2022	-0.092M
December 31, 2021	-0.113M
September 30, 2021	-0.493M
June 30, 2021	-0.475M
March 31, 2021	12.36M
December 31, 2020	11.13M
September 30, 2020	11.34M
June 30, 2020	11.40M
March 31, 2020	-1.528M

Date	Value
December 31, 2019	-0.443M
September 30, 2019	-0.7614M
June 30, 2019	0.6345M
March 31, 2019	0.7187M
December 31, 2018	0.8655M
September 30, 2018	-17.54M
June 30, 2018	-18.94M
March 31, 2018	-18.93M
December 31, 2017	-18.91M
September 30, 2017	-0.0172M
June 30, 2017	-0.0175M
March 31, 2017	-0.0278M
December 31, 2016	-0.0349M
September 30, 2016	-0.0256M
June 30, 2016	-0.0391M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-1.528M

Minimum

Mar 2020

12.36M

Maximum

Mar 2021

2.208M

Average

-0.133M

Median

Sep 2023

Cash from Investing (TTM) Benchmarks